| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.47B | 29.34B | 28.83B | 32.86B | 29.40B | 22.36B |
| Gross Profit | 5.92B | 5.94B | 5.61B | 6.14B | 4.88B | 3.34B |
| EBITDA | 3.58B | 3.50B | 3.36B | 3.94B | 2.64B | 1.19B |
| Net Income | 2.06B | 2.08B | 1.49B | 2.06B | 1.33B | -209.00M |
Balance Sheet | ||||||
| Total Assets | 19.46B | 19.51B | 19.74B | 20.63B | 22.34B | 20.32B |
| Cash, Cash Equivalents and Short-Term Investments | 1.48B | 907.00M | 1.99B | 1.20B | 2.15B | 2.52B |
| Total Debt | 3.62B | 2.89B | 5.41B | 7.68B | 10.60B | 11.93B |
| Total Liabilities | 10.01B | 9.46B | 11.81B | 14.64B | 18.24B | 17.84B |
| Stockholders Equity | 9.34B | 9.93B | 7.84B | 5.90B | 3.94B | 2.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.06B | 2.91B | 2.69B | 1.68B | 72.00M |
| Operating Cash Flow | 0.00 | 2.61B | 3.17B | 3.14B | 2.52B | 1.28B |
| Investing Cash Flow | 0.00 | -163.00M | 6.00M | -430.00M | -620.00M | -1.12B |
| Financing Cash Flow | 0.00 | -3.24B | -2.36B | -3.80B | -2.37B | 474.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $696.38B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
76 Outperform | ¥11.37B | 5.54 | ― | 4.44% | 1.68% | 15.79% | |
72 Outperform | ¥30.17B | 15.64 | ― | 1.91% | 3.14% | 11.04% | |
70 Outperform | ¥37.10B | 10.46 | ― | 4.53% | -2.57% | 3.43% | |
70 Outperform | ¥79.56B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
64 Neutral | $157.25B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |